Fingerprint
Dive into the research topics of 'Phase II evaluation of docetaxel plus exisulind in patients with androgen independent prostate carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II evaluation of docetaxel plus exisulind in patients with androgen independent prostate carcinoma
Victoria J. Sinibaldi, Kathy Elza-Brown, Jill Schmidt, Mario A. Eisenberger, Eli Rosenbaum, Samuel R. Denmeade, Roberto Pili, Janet Walczak, Sharyn D. Baker, Marianna Zahurak, Michael A. Carducci
Research output: Contribution to journal › Article › peer-review
15
Scopus
citations